SCHEMBL4599095

SCHEMBL4599095

CC(=O)N[C@@H]([C]=O)CC(=O)O

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.38
NFKB1 P19838 2/20 0.38
ALOX15 P16050 2/20 0.38
MAPT P10636 2/20 0.38
KDM4E B2RXH2 1/20 0.38
THRB P10828 1/20 0.38
PTGS2 P35354 1/20 0.38
THPO P40225 1/20 0.38
RECQL P46063 1/20 0.38
BLM P54132 1/20 0.38
ALDH1A1 P00352 1/20 0.36
GNPAT O15228 1/20 0.36
SLC22A6 Q4U2R8 1/20 0.33
CRAT P43155 1/20 0.32
TDP1 Q9NUW8 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.31
BMP1 P13497 1/20 0.30
MTNR1A P48039 2/20 0.30
MTNR1B P49286 2/20 0.30
CTRB1 P17538 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3381661 1.00 SMN1; SMN2 (0.38) SMN1; SMN2NFKB1ALOX15MAPTKDM4E
SCHEMBL9700817 0.82 GNPAT (0.41) SMN1; SMN2NFKB1ALOX15MAPTKDM4E
SCHEMBL18072526 0.81 ITGB3 (0.40) SMN1; SMN2NFKB1ALOX15MAPTKDM4E
SCHEMBL18072530 0.81 ITGB3 (0.40) SMN1; SMN2NFKB1ALOX15MAPTKDM4E
SCHEMBL5454576 0.81 KDM4E (0.32) SMN1; SMN2NFKB1ALOX15MAPTKDM4E
SCHEMBL11557961 0.81 KDM4E (0.32) SMN1; SMN2NFKB1ALOX15MAPTKDM4E
SCHEMBL200455 0.79 PLA2G2C (0.40) SMN1; SMN2NFKB1ALOX15MAPTKDM4E
SCHEMBL10617023 0.79 PLA2G2C (0.40) SMN1; SMN2NFKB1ALOX15MAPTKDM4E
SCHEMBL27880184 0.79 SLC22A6 (0.31) ALDH1A1SLC22A6TDP1
SCHEMBL7707870 0.79 BMP1 (0.49) SMN1; SMN2NFKB1ALOX15MAPTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1910309-A2 CYCLOALKYL AMINO-HYDANTOIN COMPOUNDS AND USE THEREOF FOR ß-SECRETASE MODULATION Wyeth (US) 2008-04-16 EP disclosed
WO-2007016012-A2 CYCLOALKYL AMINO-HYDANTOIN COMPOUNDS AND USE THEREOF FOR β-SECRETASE MODULATION WYETH (US) 2007-02-08 WO disclosed
US-20070027199-A1 Cycloalkyl amino-hydantoin compounds and use thereof for beta-secretase modulation WYETH (US) 2007-02-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070027199-A1 Cycloalkyl amino-hydantoin compounds and use thereof for beta-secretase modulation BACE1, BACE2, APP SMN1; SMN2 3310/4885NFKB1 1135/4885ALOX15 2080/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.